Of the MET pathway genes identified here, the majority are experimentally associated with maintaining an epithelial phenotype in cancer cells [57,58,59,60] and/or cell adhesion complexes that prevent migration and invasion [61,62,63], or are known to be downregulated during EMT [61,64,65]. This evidence concerns the gene MET and cancer.